Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: Results of a phase 2 study

Moshe Talpaz, Richard T. Silver, Brian J. Druker, John M. Goldman, Carlo Gambacorti-Passerini, Francois Guilhot, Charles A. Schiffer, Thomas Fischer, Michael W.N. Deininger, Anne L. Lennard, Andreas Hochhaus, Oliver G. Ottmann, Alois Gratwohl, Michele Baccarani, Richard Stone, Sante Tura, Francois Xavier Mahon, Sofia Fernandes-Reese, Insa Gathmann, Renaud CapdevilleHagop M. Kantarjian, Charles L. Sawyers

Research output: Contribution to journalArticle

929 Scopus citations

Fingerprint Dive into the research topics of 'Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: Results of a phase 2 study'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds